$152.86
-1.89% (Daily)
Market Cap
$192.28B
Revenue
$29.44B
Rank by MCap
#59
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Daniel P. O'Day
Headquarters
Foster City, CA
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Loading chart…